Latest Capital Raises News

Andromeda Metals has launched a $5 million capital raising via a Placement, accompanied by Placement and Broker Options, to advance its flagship Great White Project and High Purity Alumina development.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

360 Capital Mortgage REIT has successfully raised A$1.71 million by issuing 288,540 new units under a non-underwritten Unit Purchase Plan, strengthening its capital base without incurring brokerage costs.

Lightning Minerals Ltd’s securities remain suspended after missing a deadline to announce a major acquisition and capital raising, raising questions about the company’s next moves.

Multistack International Limited is set to sell all assets and liabilities of its operating subsidiary to Super Link Company Limited, marking a strategic exit from its loss-making industrial cooling business. The company will retain a small net asset base while exploring new business opportunities.

Atomo Diagnostics has successfully closed a Share Purchase Plan and secured shareholder approval for a Tranche 2 Placement, raising a combined $1.53 million to support its ongoing operations.

Lord Resources has completed its entitlement offer, raising $568,925 with a 40.82% take-up rate, leaving a significant shortfall of 45.8 million shares. The company plans to allocate the remaining shares to interested parties as it advances exploration at its Ilgarari Copper Project.

Alvo Minerals has successfully closed its retail entitlement offer, raising $810,985 and bringing total proceeds from its recent capital raise to $1.56 million. The funds will support ongoing exploration at its Palma Cu/Zn Project and other mineral ventures in Brazil.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.

Uvre Limited reports standout rock chip assays up to 18.4g/t gold from its pending acquisition of Otagold Ltd, setting the stage for a maiden drilling campaign at the Waitekauri project near OceanaGold’s Waihi mine.

Iltani Resources has successfully closed a Share Purchase Plan raising $965,000 and secured an additional $200,000 via a private placement, bringing total recent capital raised to nearly $3 million. These funds will fuel exploration at its promising Orient Silver-Indium Project and other ventures.